1. South Korea Stocks

  2. •

    Consumer Cyclical

  3. •

    Apparel - Footwear & Accessories
INBIOGEN Co., Ltd.

INBIOGEN Co., Ltd.

101140.KS
INBIOGEN Co., Ltd.KR flagKorea Exchange
6,080.00
KRW
+530.00
- -
60.71BMarket Cap

Total Valuation

INBIOGEN Co., Ltd. carries a market capitalization of 60.71B, placing it among publicly traded companies globally. Its enterprise value stands at 97.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap60.71B
Enterprise Value97.13B

Share Statistics

INBIOGEN Co., Ltd. currently has 9.98M shares outstanding.

Shares Outstanding9.98M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

INBIOGEN Co., Ltd. trades at a trailing price-to-earnings ratio of 9.26. The price-to-sales ratio is 17.74, and the price-to-book ratio stands at 10.97.

PE Ratio9.26
PS Ratio17.74
PB Ratio10.97
P/TBV Ratio0.68
P/FCF Ratio-22.76
P/OCF Ratio-22.49

Enterprise Valuation

EV / Sales17.84
EV / EBITDAN/A
EV / EBITN/A
EV / FCFN/A

Financial Position

INBIOGEN Co., Ltd. maintains a current ratio of 1.57, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 2.87, indicating elevated leverage, while an interest coverage ratio of -37.88 demonstrates limited ability to service its debt obligations.

Current Ratio1.57
Quick Ratio0.72
Debt / Equity2.87
Debt / EBITDA-1.03
Interest Coverage-37.88

Financial Efficiency

INBIOGEN Co., Ltd. posts a return on equity of -100.93 and a return on invested capital of -3.42.

Return on Equity (ROE)-100.93
Return on Assets (ROA)-11.61
Return on Invested Capital (ROIC)-3.42
Return on Capital Employed (ROCE)153.92
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover126.19

Stock Price Statistics

INBIOGEN Co., Ltd.'s stock has declined approximately -44.42413% over the past 52 weeks. The 50-day moving average sits at 7,111.40, while the 200-day moving average is 10,121.60.

Beta (5Y)N/A
52-Week Price Change-44.42413%
50-Day Moving Average7,111.40
200-Day Moving Average10,121.60
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, INBIOGEN Co., Ltd. generated 5.44B in revenue and converted that into -18.13B in net income, yielding earnings per share of -1,818.10. EBITDA reached -3.99B, while operating income came in at -3.99B.

Revenue5.44B
Gross Profit-482.67M
Operating Income-3.99B
Pretax Income-18.13B
Net Income-18.13B
EBITDA-3.99B
EBIT-3.99B
Earnings Per Share (EPS)-1,818.10

Balance Sheet

INBIOGEN Co., Ltd. holds 3.53B in cash and equivalents against 4.11B in total debt, resulting in a net debt position of -32.63M. Total book value stands at 8.80B, with working capital of 2.81B providing operational flexibility.

Cash & Cash Equivalents3.53B
Total Debt4.11B
Net Debt-32.63M
Equity (Book Value)8.80B
Book Value Per Share881.25
Working Capital2.81B

Cash Flow

INBIOGEN Co., Ltd. produced -4.29B in operating cash flow over the past twelve months. After subtracting -56.21M in capital expenditures, free cash flow totaled -4.35B - equivalent to -435.60 per share.

Operating Cash Flow-4.29B
Capital Expenditures-56.21M
Free Cash Flow-4.35B
FCF Per Share-435.60

Margins

INBIOGEN Co., Ltd. operates with a gross margin of -8.87, reflecting its pricing power and cost economics. The operating margin of -73.31 and net profit margin of -333.01 provide insight into operational efficiency.

Gross Margin-8.87
Operating Margin-73.31
Pretax Margin-333.01
Profit Margin-333.01
EBITDA Margin-73.31

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield-3.41
FCF Yield-4.39

Stock Splits

INBIOGEN Co., Ltd.'s most recent stock split took place on September 21, 2023 with a 20:1 split ratio.

Last Split Date9/21/2023
Split Ratio20:1

Scores

INBIOGEN Co., Ltd. posts an Altman Z-Score of 10.82, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score10.82